Get the Stockscreener App
37.14
3.88%
-1.50
After Hours:
37.14
Procept Biorobotics Corp stock is traded at $37.14, with a volume of 1.09M.
It is down -3.88% in the last 24 hours and down -3.78% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$38.64
Open:
$38.36
24h Volume:
1.09M
Relative Volume:
1.02
Market Cap:
$2.07B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-21.85
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-8.70%
1M Performance:
-3.78%
6M Performance:
-35.51%
1Y Performance:
-53.80%
1-Day Range:
$36.90
$38.59
1-Week Range:
$36.90
$41.51
52-Week Range:
$36.90
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
37.14 | 2.09B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Procept Biorobotics stock hits 52-week low at 37.07 USD - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Down 4.3%Here's What Happened - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $38.56 Million Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept Biorobotics stock hits 52-week low at 37.07 USD By Investing.com - Investing.com Nigeria
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sandler Capital Management Lowers Stock Holdings in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Polar Asset Management Partners Inc. Buys Shares of 71,980 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Adage Capital Partners GP L.L.C. Acquires Shares of 50,000 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Baird Financial Group Inc. Acquires 15,880 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Alliancebernstein L.P. Boosts Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Eventide Asset Management LLC Buys 227,088 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation Consolidation Zone May Signal Accumulation2025 Buyback Activity & Stepwise Trade Signal Guides - beatles.ru
PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded to Outperform at Oppenheimer - MarketBeat
Graham Capital Management L.P. Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Update Report: What is the next catalyst for PROCEPT BioRobotics CorporationShare Buyback & Real-Time Volume Surge Alerts - خودرو بانک
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
Best data tools to analyze PROCEPT BioRobotics Corporation stockJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Driehaus Capital Management LLC Sells 188,982 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
What makes PROCEPT BioRobotics Corporation stock attractive todayQuarterly Earnings Summary & Daily Entry Point Trade Alerts - خودرو بانک
Institutional scanner results for PROCEPT BioRobotics CorporationMarket Sentiment Summary & AI Forecast for Swing Trade Picks - Newser
Will PROCEPT BioRobotics Corporation stock go up soonWeekly Stock Summary & Daily Stock Trend Reports - Newser
Short interest data insights for PROCEPT BioRobotics CorporationWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Will PROCEPT BioRobotics Corporation bounce back from current supportWeekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Using AI based signals to follow PROCEPT BioRobotics CorporationExit Point & AI Enhanced Trading Alerts - Newser
Relative Strength Alert For PROCEPT BioRobotics - Nasdaq
PROCEPT BioRobotics Corporation stock daily chart insights2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - Newser
Using data tools to time your PROCEPT BioRobotics Corporation exitJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
What MACD signals say about PROCEPT BioRobotics CorporationJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Can PROCEPT BioRobotics Corporation hit a new high this monthInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Is PROCEPT BioRobotics Corporation building a consolidation baseWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Ranking PROCEPT BioRobotics Corporation among high performing stocks via tools2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Statistical indicators supporting PROCEPT BioRobotics Corporation’s strengthJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Real time social sentiment graph for PROCEPT BioRobotics CorporationDividend Hike & Smart Allocation Stock Reports - Newser
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionWeekly Stock Recap & High Accuracy Trade Alerts - Newser
What is the next catalyst for PROCEPT BioRobotics CorporationJuly 2025 Technicals & Stepwise Swing Trade Plans - خودرو بانک
Is PROCEPT BioRobotics Corporation trending in predictive chart modelsWall Street Watch & Weekly Top Gainers Trade List - Newser
PROCEPT BioRobotics Corporation stock retracement – recovery analysisTrade Signal Summary & Technical Pattern Alert System - Newser
Applying Elliott Wave Theory to PROCEPT BioRobotics CorporationEarnings Growth Summary & Entry and Exit Point Strategies - Newser
What’s the recovery path for long term holders of PROCEPT BioRobotics Corporation2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Procept Offers Attractive Risk-Reward, Oppenheimer Says - MarketScreener
Procept BioRobotics stock upgraded by Oppenheimer on attractive risk-reward - Investing.com
Procept BioRobotics upgraded to Outperform from Perform at Oppenheimer - TipRanks
Oppenheimer Upgrades PROCEPT BioRobotics to Outperform From Market Perform, Price Target is $60 - MarketScreener
Using R and stats models for PROCEPT BioRobotics Corporation forecastingJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):